Patient-reported outcomes used actively in cancer patients undergoing antineoplastic treatment: A mini-review of the Danish landscape.
EHealth
EPRO
PREM
PRO
PROM
Patient perspective
Patient satisfaction
Patient-reported outcomes
Journal
Computational and structural biotechnology journal
ISSN: 2001-0370
Titre abrégé: Comput Struct Biotechnol J
Pays: Netherlands
ID NLM: 101585369
Informations de publication
Date de publication:
Dec 2024
Dec 2024
Historique:
received:
22
09
2023
revised:
27
11
2023
accepted:
27
11
2023
medline:
11
12
2023
pubmed:
11
12
2023
entrez:
11
12
2023
Statut:
epublish
Résumé
Many studies using Patient-reported outcomes (PRO) data have been conducted to monitor symptoms and health-related quality of life during follow-up after cancer treatment. However new ways of using (e)PROs have emerged. We aimed to explore the Danish landscape of the use of PRO in a research setting, where PRO is used actively in cancer patients undergoing treatment, and give an overview of how it is embraced by patients and clinicians. A literature search was performed in June 2023, using the keywords Denmark, cancer, and patient-reported outcomes. An expert on literature searches identified the search terms, and double screening was performed at both abstract and screening levels and full-text stage. The software tool Covidence was used. 467 articles were retrieved and 19 studies were included. They described the type of ePRO instrument used and the application of active ePRO i.e. a dialogue tool in the clinical encounter, release of alerts to clinicians, and enhancement of self-management. Finally, a development in the use of active ePROs over time is elucidated and we show how it is embraced by patients and clinicians. This mini-review gives an overview of how ePRO solutions are tested in oncological research in Denmark and embraced by patients and clinicians. ePRO solutions in a Danish setting seem well-suited for self-management. However, if more impact is warranted, clinicians need to engage in reviewing and using ePROs. Moreover, for successful implementation, the integration of ePROs in electronic health records must be supported by IT specialists and management.
Identifiants
pubmed: 38076643
doi: 10.1016/j.csbj.2023.11.054
pii: S2001-0370(23)00468-3
pmc: PMC10704259
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
23-30Informations de copyright
© 2023 The Authors.
Références
Qual Life Res. 2012 Oct;21(8):1305-14
pubmed: 22048932
Rheumatol Adv Pract. 2022 Aug 17;6(3):rkac065
pubmed: 36071947
J Clin Med. 2021 Apr 24;10(9):
pubmed: 33923176
Qual Life Res. 2011 Dec;20(10):1727-36
pubmed: 21479777
Qual Life Res. 2016 Mar;25(3):525-34
pubmed: 26790427
J Clin Oncol. 2021 Mar 1;39(7):734-747
pubmed: 33417506
Breast Cancer. 2021 Sep;28(5):1096-1099
pubmed: 33837509
Clin Otolaryngol. 2022 Sep;47(5):561-567
pubmed: 35634790
Acta Oncol. 2020 Apr;59(4):444-452
pubmed: 32000559
J Patient Rep Outcomes. 2021 Jun 23;5(1):47
pubmed: 34160732
Acta Oncol. 2021 Apr;60(4):419-425
pubmed: 33641578
Acta Oncol. 2022 Dec;61(12):1473-1476
pubmed: 36494192
JAMIA Open. 2019 Apr;2(1):73-80
pubmed: 30976756
J Patient Rep Outcomes. 2023 Nov 30;7(1):125
pubmed: 38032401
Clin Cancer Res. 2018 Apr 15;24(8):1780-1784
pubmed: 29237718
Support Care Cancer. 2022 Feb;30(2):1427-1439
pubmed: 34524527
J Patient Rep Outcomes. 2022 Jun 20;6(1):70
pubmed: 35723827
JMIR Res Protoc. 2022 Sep 15;11(9):e36632
pubmed: 36107483
Qual Life Res. 2021 Nov;30(11):3015-3033
pubmed: 32651805
BMJ Open. 2022 Oct 31;12(10):e060242
pubmed: 36316074
Acta Oncol. 2022 May;61(5):602-607
pubmed: 35311443
Patient. 2018 Dec;11(6):591-598
pubmed: 29968179
J Med Internet Res. 2020 Oct 29;22(10):e19685
pubmed: 33118954
Am J Clin Oncol. 2017 Oct;40(5):464-469
pubmed: 25811297
Expert Rev Pharmacoecon Outcomes Res. 2011 Oct;11(5):561-70
pubmed: 21958101
BMJ. 2021 Jul 21;374:n1647
pubmed: 34289996
Acta Oncol. 2021 Dec;60(12):1668-1677
pubmed: 34403293
Med Care. 2019 May;57 Suppl 5 Suppl 1:S59-S65
pubmed: 30985598
Breast J. 2019 Mar;25(2):269-272
pubmed: 30761667
J Clin Oncol. 2016 Feb 20;34(6):557-65
pubmed: 26644527
Health Qual Life Outcomes. 2020 Jul 11;18(1):225
pubmed: 32653005
J Patient Rep Outcomes. 2019 Mar 21;3(1):19
pubmed: 30900035
J Patient Rep Outcomes. 2020 Jul 8;4(1):55
pubmed: 32642867
Cancer Med. 2020 May;9(9):3078-3087
pubmed: 32154663
Radiother Oncol. 2016 May;119(2):221-8
pubmed: 27178143
Acta Oncol. 2020 May;59(5):603-607
pubmed: 32056473
J Patient Rep Outcomes. 2019 Aug 22;3(1):56
pubmed: 31440865
Int J Gynecol Cancer. 2020 Sep;30(9):1444-1449
pubmed: 32586892
J Patient Rep Outcomes. 2017;1(1):1
pubmed: 29757324
BMC Health Serv Res. 2020 Nov 17;20(1):1047
pubmed: 33198756
J Med Internet Res. 2019 Jan 24;21(1):e10875
pubmed: 30679145
Health Informatics J. 2020 Mar;26(1):129-140
pubmed: 30516095
Ann Oncol. 2022 Sep;33(9):878-892
pubmed: 35462007
J Patient Rep Outcomes. 2022 Jan 21;6(1):8
pubmed: 35061112
BMC Cancer. 2022 Jul 2;22(1):726
pubmed: 35780095
BMJ Qual Saf. 2018 Oct;27(10):852-856
pubmed: 30021802
J Clin Epidemiol. 1997 Apr;50(4):441-50
pubmed: 9179103
J Med Internet Res. 2020 Apr 9;22(4):e14896
pubmed: 32271150
JCO Clin Cancer Inform. 2022 Jan;6:e2100137
pubmed: 34985914
Arch Phys Med Rehabil. 2020 Oct;101(10):1796-1812
pubmed: 32416149
J Clin Oncol. 1993 Mar;11(3):570-9
pubmed: 8445433
Patient Relat Outcome Meas. 2019 Mar 27;10:117-127
pubmed: 30988648
J Patient Rep Outcomes. 2018 Oct 03;2:46
pubmed: 30363333
Clin Cancer Res. 2016 Apr 1;22(7):1553-8
pubmed: 26758559
J Patient Rep Outcomes. 2023 Jul 18;7(1):72
pubmed: 37462855
Qual Life Res. 2019 Mar;28(3):621-627
pubmed: 30448911
J Oncol Pract. 2014 Sep;10(5):e299-306
pubmed: 24986113
J Cancer Surviv. 2021 Aug;15(4):485-496
pubmed: 33415653
J Oncol Pract. 2014 Jul;10(4):e215-22
pubmed: 24301843
J Patient Rep Outcomes. 2020 Oct 30;4(1):88
pubmed: 33125537
Support Care Cancer. 2017 Apr;25(4):1323-1355
pubmed: 28058570
Breast J. 2019 Nov;25(6):1295-1296
pubmed: 31353754
Int J Qual Health Care. 2022 Mar 31;34(Supplement_1):ii49-ii58
pubmed: 35357442
Lung Cancer. 2021 Dec;162:1-8
pubmed: 34634754
Res Involv Engagem. 2019 Nov 20;5:36
pubmed: 31832240
Acta Oncol. 2023 Mar;62(3):329-333
pubmed: 36995173